Printed from acutecaretesting.org
Articles and journal scans about Cardiac markers
Article
March 2018
Benefits of point-of-care testing in the Emergency Department
This article explores the potential benefits of point-of-care testing in the ED. Price and St. John provide a detailed description on how to approach four common aspects of point-of-care testing (POCT) in the ED, specifically, the challenges of adopting POCT, the impact of POCT on clinical decisions, the impact of...
Point-of-care testing
Cardiac markers
Natriuretic peptide
Article
October 2017
Natriuretic peptide measurement in heart failure
This paper is an up-to-date account of research and current clinical practice guideline recommendations. Chris Higgins summarizes the recommendations of 2 new guidance documents on the use of natriuretic peptides in heart failure. The first document is a systematic review of published research (up to 2016) on the role ...
Natriuretic peptide
Cardiac markers
Journal Scan
May 2016
Troponin values in the elderly
Cardiac troponin T (cTnT) is the biomarker of choice for diagnosis of acute coronary syndromes (myocardial infarction (MI) and unstable angina).
The cardiac muscle cell (myocyte) necrosis, consequent on ischemia that characterises MI, results in release of troponins from necrosed cardiac myocytes to blood and rising...
Troponins
Cardiac markers
Article
December 2014
Role of POCT in the management of patients with acute dyspnea
This short review aims to put the diagnostic options provided by state-of-the-art POCT technology into perspective with the clinical challenges faced by physicians treating patients presenting with acute dyspnea.
Natriuretic peptides, hemoglobin, D-dimers and venous blood gases play a key role in the early...
Cardiac markers
Blood gases/acid-base
Hemoglobins
Natriuretic peptide
Article
October 2014
Point-of-care cardiac markers in the Emergency Department are safe, reduce admissions and do not impact on the 4-hour target
Barnsley Emergency Department (ED), which recruited patients into the RATPAC trial, initiated a point-of-care (POC) pathway for low-risk chest pain patients from December 2011.
All patients who underwent POC testing for chest pain between December 2011 and July 2012 were identified. Patient notes were then examined...
Cardiac markers
Point-of-care testing
Process optimization
Troponins
Article
October 2014
POCT in emergency rooms: One key factor for process streamlining with Lean Management
In the past years, emergency rooms (ER) all over Germany, especially those of maximum-care hospitals, have been faced with an increasing number of patients. This is caused by a variety of factors, including demographic changes, inflexible ambulant services and an overreaching demand for healthcare services.
ER...
Cardiac markers
Point-of-care testing
Process optimization
Hemoglobins
D-dimer
Troponins
CRP
Article
July 2014
The value of point-of-care testing in deteriorating ward patients
Point-of-care testing (POCT) for key laboratory variables may help clinicians assess the level of acuteness and the level of care necessary in the management of deteriorating ward patients.
We used a multibiomarker POCT panel including B-type natriuretic peptide (BNP), D-dimer, myoglobin (Myo), creatine kinase MB...
Cardiac markers
Point-of-care testing
Coagulation/fibrinolysis
D-dimer
Troponins
Natriuretic peptide
Kidneys/fluids
Article
April 2014
Natriuretic peptide testing for heart failure diagnosis, inpatient management and outpatient cardiac care
The use of natriuretic peptides like B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) has increased during the last decade and so has the medical evidence of their utility.
This article highlights natriuretic peptide synthesis and release. Based on essential clinical trials the article gives medical...
Cardiac markers
Natriuretic peptide
Article
January 2014
The Role of Cardiac Biomarkers in the Diagnosis and Management of Patients Presenting with Suspected Acute Coronary Syndrome
Reprinted from Ann Lab Med 2013 Sep; 33(5):309-18.
Christenson E, Christenson RH: "The role of cardiac biomarkers in the diagnosis and management of patients presenting with suspected acute coronary syndrome".
Myocardial infarction (MI) is the leading cause of death in the developed world. Biomarkers have an...
Cardiac markers
Troponins
Article
July 2013
How to use high-sensitivity cardiac troponin assays most effectively in clinical practice
Recently developed high-sensitivity cardiac troponin (cTn) assays can measure approximately 10 times lower concentrations with high precision (coefficient of variation, <10 % at the 99th percentile of the upper reference limit) than conventional assays, and can measure cTn concentrations in at least 50 % of a reference ...
Cardiac markers
Troponins
CRP
Natriuretic peptide
Kidneys/fluids